Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NANCY L CARTERON

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1669582458
CMS profile
439317
Location
SAN FRANCISCO, CA

General Payments · PY2018–2024

$46,618.27

  • Reported across 22 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$13,499.91

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $11,990.00 3
Travel and Lodging $1,423.38 5
Food and Beverage $86.53 5

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Boehringer Ingelheim Pharmaceuticals, Inc. $7,909.91 11
E.R. Squibb & Sons, L.L.C. $5,590.00 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $25,807.02 2
PY2019 $1,809.73 3
PY2021 $2,596.00 1
PY2023 $2,905.61 3
PY2024 $13,499.91 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018201920212023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Boehringer Ingelheim Pharmaceuticals, Inc. $628.98 09/26/2024 Travel and Lodging Undisputed 01/23/2026 1118103399 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $212.00 10/25/2024 Travel and Lodging Undisputed 01/23/2026 1118103395 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $275.65 10/25/2024 Travel and Lodging Undisputed 01/23/2026 1118103397 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $166.75 10/28/2024 Travel and Lodging Undisputed 01/23/2026 1118103415 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $6.20 11/01/2024 Food and Beverage Undisputed 01/23/2026 1118103403 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $7.49 11/01/2024 Food and Beverage Undisputed 01/23/2026 1118103405 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $11.75 11/01/2024 Food and Beverage Undisputed 01/23/2026 1118103407 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $26.09 11/01/2024 Food and Beverage Undisputed 01/23/2026 1118103409 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $6,400.00 12/05/2024 Consulting Fee Undisputed 01/23/2026 1118103401 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $35.00 12/05/2024 Food and Beverage Undisputed 01/23/2026 1118103411 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $140.00 12/05/2024 Travel and Lodging Undisputed 01/23/2026 1118103413 CMS
E.R. Squibb & Sons, L.L.C. $2,580.00 07/26/2024 Consulting Fee Undisputed 01/23/2026 1101835489 CMS
E.R. Squibb & Sons, L.L.C. $3,010.00 12/30/2024 Consulting Fee Undisputed 01/23/2026 1101835595 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2021, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2021 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.